This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q67955620
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована у вересні 1991 wetenschappelijk artikel im September 1991 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 September 1991 artículu científicu espublizáu en setiembre de 1991
p:P577
wds:Q67955620-AB7230AB-563E-4606-91CB-2DFDC624945D
wdt:P577
1991-09-01T00:00:00Z
p:P407
wds:Q67955620-4AFB26FB-9679-46EA-82A0-ED373A84E53B
wdt:P407
wd:Q1860
p:P2093
wds:Q67955620-4A23CC23-464D-4709-B377-CA7F97342A71 wds:Q67955620-D03CA920-5C42-4769-AD62-22E98BE187C4 wds:Q67955620-F1D4BA0B-A9D0-4DFE-99FC-F3C884472893 wds:Q67955620-BC7B5D0E-20E6-4AF2-AB49-EEC4757791D6 wds:Q67955620-A0E73017-C976-48C5-906A-BE8D38CC0FFD wds:Q67955620-86B2F193-9451-4F2C-BDAC-D713EFD254C1 wds:Q67955620-8DA6EDFD-F250-4C53-BD5E-ABF8AD87B499 wds:Q67955620-868E6FC7-10A0-4AA6-BD3D-8F579437F7CC wds:Q67955620-664D77BD-867A-46F6-A84F-312610893260 wds:Q67955620-78DDEDD8-D4C5-4006-AF94-9402797FB937
wdt:P2093
LeMaistre CF Fishwild D Rosen S Saria E Kornfeld S Byers V Scannon P Frankel A Meneghetti C Drajesk J
rdfs:label
Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma
skos:prefLabel
Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma
schema:name
Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma
p:P1476
wds:Q67955620-6546594D-40C7-43D6-A97F-5C08C47FA9A0
wdt:P1476
Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma
p:P304
wds:Q67955620-84344C43-3F95-4BFB-A98C-F04BC556E953
wdt:P304
1173-1182
p:P31
wds:Q67955620-9378A8D6-92E6-4316-868E-23E02A3E45C5
wdt:P31
wd:Q13442814
p:P921
wds:Q67955620-64CD379B-28F7-41E3-A0C6-3E054E6B79C8
wdt:P921
wd:Q5452194
p:P698
wds:Q67955620-F6002ADD-FACA-4F65-B0E8-4B06B1CB8998
wdtn:P698
n9:1878584
wdt:P698
1878584
p:P1433
wds:Q67955620-5F38BAA2-4329-4420-B207-0CBCDBAB115B
wdt:P1433
wd:Q885070
p:P433
wds:Q67955620-824EEAA3-6F98-4DF9-B328-4B35194C1661
p:P478
wds:Q67955620-7FCB7F87-0BB8-4B0A-A5CD-B1E326A027FD
wdt:P433
5
wdt:P478
78